By Dr David Herrmann

Conference Papers

Burns C; Murphy K; Cock T-A; Devlin M; Herrmann D; Timpson P, 2023, 'The effect of adding a selective FAK inhibitor AMP945 to FOLFIRINOX in a model of pancreatic cancer.', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 02 June 2023 - 06 June 2023

Pinho AV; Van Bulck M; Chantrill L; Arshi M; Herrmann D; Vennin C, 2019, 'ROBO2 is a stroma suppressor gene in the pancreas through regulation of TGF-beta', in CANCER IMMUNOLOGY RESEARCH, AMER ASSOC CANCER RESEARCH, http://dx.doi.org/10.1158/2326-6074.CRICIMTEATIAACR18-A100

Warren SC; Magenau A; Nobis M; Herrmann D; Mélénec P; Anderson KI; Sansom OJ; Morton JP; Welch HC; Timpson P, 2018, 'Unmixing spectrally overlapping FRET biosensors in vivo using multispectral FLIM (Conference Presentation)', in Periasamy A; So PT; Xie XS; König K (eds.), Multiphoton Microscopy in the Biomedical Sciences XVIII, SPIE, pp. 23 - 23, presented at Multiphoton Microscopy in the Biomedical Sciences XVIII, 27 January 2018 - 01 February 2018, http://dx.doi.org/10.1117/12.2290152

Herrmann D; Cheng S; Driller K; Partanen J; Neubser A, 2009, 'Analysis of facial and palatal defects in Fgfr1 mutant mice', in MECHANISMS OF DEVELOPMENT, ELSEVIER SCIENCE BV, SCOTLAND, Edinburgh, pp. S166 - S166, presented at 16th Annual Conference of the International-Society-of-Development-Biologists, SCOTLAND, Edinburgh, 06 September 2009 - 10 September 2009, http://dx.doi.org/10.1016/j.mod.2009.06.384

Back to profile page